Serum METRNL Concentration in Type 2 Diabetes

Completed

• Conditions: Diabetes Mellitus, Type 2

• Registration Number: NCT03194100
• Lead Sponsor: Chungnam National University Hospital

Brief Summary

The investigators measured serum METRNL levels in newly diagnosed patients with type 2 diabetes (T2DM) compared with normal glucose tolerance or prediabetes and explored the correlations between its serum levels and various metabolic parameters

Detailed Description

Not available

Study Timeline

• Study Start: 2014-01-01
• Primary Completion: 2016-11-30
• Study Completion: 2016-11-30
• Status Verified: 2017-06
• Study First Submitted: 2017-06-18
• Study First Submitted QC: 2017-06-20
• Last Update Submitted: 2017-06-20
• Study First Posted: 2017-06-21
• Last Update Posted: 2017-06-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 125

Inclusion Criteria

• Subjects who have not been diagnosed diabetes mellitus

Exclusion Criteria

• Person with diabetes who were treated with oral hypoglycemic agent or insulin
• Individuals with type 1 diabetes, gestational diabetes, active hepatitis/liver cirrhosis, chronic renal failure on hemodialysis, congestive heart failure, or other known major disease

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
serum METRNL concentration	on the 1 day of oral glucose tolerance test